Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to ...
Viral DNA that is usually dismissed when sequencing the human genome could help to uncover useful information about complex diseases.